Eye movement desensitization and reprocessing (EMDR) in patients with a personality disorder by Hafkemeijer, L. et al.
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=zept20
European Journal of Psychotraumatology
ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/zept20
Eye movement desensitization and reprocessing
(EMDR) in patients with a personality disorder
Laurian Hafkemeijer , Ad de Jongh , Job van der Palen & Annemieke
Starrenburg
To cite this article: Laurian Hafkemeijer , Ad de Jongh , Job van der Palen & Annemieke
Starrenburg (2020) Eye movement desensitization and reprocessing (EMDR) in patients
with a personality disorder, European Journal of Psychotraumatology, 11:1, 1838777, DOI:
10.1080/20008198.2020.1838777
To link to this article:  https://doi.org/10.1080/20008198.2020.1838777
© 2020 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group.
Published online: 19 Nov 2020.
Submit your article to this journal 
Article views: 1378
View related articles 
View Crossmark data
BASIC RESEARCH ARTICLE
Eye movement desensitization and reprocessing (EMDR) in patients with a 
personality disorder
Laurian Hafkemeijer a, Ad de Jongh b,c,d,e,f, Job van der Palen g and Annemieke Starrenburg a
aDepartment of Adult Psychiatry, GGZ Delfland, Delft, The Netherlands; bAcademic Centre for Dentistry Amsterdam (ACTA), University of 
Amsterdam and VU University Amsterdam, Amsterdam, The Netherlands; cResearch Department, PSYTREC, Bilthoven, The Netherlands; 
dSchool of Health Sciences, Salford University, Manchester, UK; eInstitute of Health and Society, University of Worcester, Worcester, UK; 
fSchool of Psychology, Queen’s University Belfast, Belfast, Northern Ireland; gDepartment of Research Methodology, Measurement and 
Data Analysis, University of Twente, Enschede & Department of Epidemiology, Medisch Spectrum Twente, Enschede, The Netherlands
ABSTRACT
Background: Little is known about the effects of targeting memories of adverse (childhood) 
events in people with a personality disorder (PD).
Objective: Determining the effectiveness of brief EMDR therapy in individuals with PD.
Method: In a randomized-controlled trial, 97 outpatients with a PD as main diagnosis were 
allocated to either five (90 minutes) sessions of EMDR therapy (n = 51) or a waiting list (WL) 
control condition (n = 46) followed by 3 months of treatment as usual for their PD. 
Individuals with posttraumatic stress disorder (PTSD) were excluded. Measurements were 
performed on psychological symptoms, psychological distress, and personality dysfunction-
ing. Outcomes were compared at baseline, post-treatment, and at 3-month follow up. Data 
were analysed as intent-to-treat with linear mixed models.
Results: EMDR therapy yielded significant improvements with medium to large effect sizes 
for the primary outcomes after treatment, i.e. psychological symptoms (EMDR: d =.42; 
control group: d =.07), psychological distress (EMDR: d =.69; control group: d =.29), and 
personality functioning (EMDR: d =.41; control group: d = −.10) within groups. At 3-month 
follow-up, after 3 months of TAU, improvements were maintained. Significant differences 
were found between both groups regarding all outcome measures in favour of the EMDR 
group at post-treatment (ds between −.62 and −.65), and at follow-up, after 3 months of 
TAU (ds between −.45 and −.53).
Conclusions: The results suggest that EMDR therapy can be beneficial in the treatment of 
patients with PDs. More rigorous outcome research examining long-term effects and using 
a longer treatment track is warranted.
Desensibilización y reprocesamiento por movimiento ocular (EMDR) 
en pacientes con un trastorno de la personalidad.
Antecedentes: Se sabe poco acerca del efecto que tiene la focalización de los recuerdos de 
los eventos adversos (de la infancia) en las personas con un trastorno de la personalidad 
(PD, por sus siglas en inglés).
Objetivo: Determinar la eficacia de la terapia breve EMDR en individuos con PD.
Método: En un ensayo controlado aleatorio, 97 pacientes ambulatorios con una PD como 
diagnóstico principal fueron asignados a cinco sesiones (de 90 minutos c/u) de terapia 
EMDR (n=51) o a una condición de control en lista de espera (WL, por sus siglas en inglés) 
(n=46) seguidas de tres meses de tratamiento habitual para su PD. Se excluyeron los 
individuos con trastorno de estrés postraumático. Se realizaron mediciones de los 
síntomas psicológicos, malestar psicológico, y disfunción de la personalidad. Los resultados 
se compararon al inicio, después del tratamiento y a los 3 meses de seguimiento. Los datos 
se analizaron como intención de tratar con modelos lineales mixtos.
Resultados: La terapia EMDR produjo mejoras significativas con tamaños de efecto media-
nos a grandes para los resultados primarios después del tratamiento, es decir, síntomas 
psicológicos (EMDR: d =.42; grupo control: d =.07), malestar psicológico (EMDR: d =.69; 
grupo control: d =.29), y disfunción de la personalidad (EMDR: d =.41; grupo control: 
d = −.10) dentro de los grupos. A los 3 meses de seguimiento, después de tres meses de 
TAU, se mantuvieron las mejoras. Se encontraron diferencias significativas entre ambos 
grupos con respecto a todas las medidas de resultados a favour del grupo EMDR en el 
postratamiento (ds entre −.62 y −.65) y el seguimiento (ds entre 0,21 y 0,25), después de tres 
meses de TAU (ds entre −.45 y −.53).
Conclusiones: Los resultados sugieren que la terapia EMDR puede ser beneficiosa para los 
pacientes con PD. Se recomienda una investigación más estricta de los resultados, que 
examine los efectos a largo plazo y utilice una duración más larga del tratamiento.
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人格障碍患者中的眼动脱敏再加工（EMDR） 
方法:在一项随机对照试验中, 将以PD为主要诊断的97位门诊患者分为接受5次 (90分钟) 
EMDR的治疗组 (n = 51) 或接受3个月往常PD治疗的等待名单 (WL) 对照组 (n = 46) 。排除 
了患有创伤后应激障碍 (PTSD) 的个体。对心理症状, 心理困扰和人格障碍进行了测量。比 
较基线, 治疗后和3个月随访时的结果。使用线性混合模型将对数据进行意向性分析。
结果:EMDR疗法在治疗后的主要结果上取得了中等至较大效应量的显著改善, 即组内的心 
理症状 (EMDR组:d = 0.42;对照组:d =.07), 心理困扰 (EMDR组:d = 0.69;对照组:d =.29), 人格 
失调 (EMDR:d =.41;对照组:d = −.10) 。在3个月 TAU 后的3个月的随访时, 经过, 改善得到维 
持。两组在所有结果指标方面均存在显著差异, 在治疗后 (d在-0.6至-.65之间) 和在TAU三 
个月后随访时 (d在-.45和-.53之间) EMDR组都表现更加。
结论:结果表明, EMDR疗法可有效治疗PD患者。需要进行更严格的结果研究, 以考查长期效 
果并使用更长的治疗途径。
1. Introduction
Personality disorders (PDs) are one of the most com-
mon mental health conditions. Approximately 3–15% 
(Bamelis, Evers, Spinhoven, & Arntz, 2014) of the gen-
eral population and 40–50% of patients in mental 
health-care settings (Newton-Howes et al., 2010) meet 
the diagnostic criteria for a PD regardless whether the 
PD diagnosis is a primary or secondary (i.e. comorbid) 
diagnosis. Several studies indicate poorer interpersonal 
and occupational functioning in patients with PDs as 
compared to patients with other psychiatric disorders 
(Oltmanns, Melley, & Turkheimer, 2002). Accordingly, 
individuals with PDs exert a high individual, societal 
and economic burden of disease (Soeteman, Hakkaart- 
van Roijen, Verheul, & Busschbach, 2008), causing 
a strong demand on psychiatric, general health and 
social care services making efficient and effective treat-
ment a priority.
One of the factors that has been found to be highly 
associated with the development of personality 
pathology is a history of distressing and traumatic 
life experiences, such as emotional or physical abuse 
(Lobbestael, Arntz, & Bernstein, 2010). Rates of child-
hood maltreatment among individuals with PDs are 
high, with 73% of their sample reporting abuse and 
82% reporting neglect (Battle et al., 2004). Research 
shows that also events that do not specifically fulfill 
the A-criterion of a posttraumatic stress disorder 
(PTSD) classification are associated with core features 
of PD (e.g., Kaplan, Pelcovitz, & Labruna, 1999). For 
example, Porter et al. (2020) found both emotional 
abuse (OR: 38.1) and neglect (OR: 17.7) to be 
strongly associated with the presence of borderline 
personality disorder (BPD). Given the prevalence rate 
of PTSD in patients diagnosed with PD other than 
BPD (e.g., 22%; Zanarini et al., 1998) it is likely that 
a considerable proportion of patients with a PD do 
not meet diagnostic criteria for PTSD.
With regard to the treatment of PDs, several studies 
evaluated the outcome of treatment that pertained to 
traumatic events underlying PTSD thereby examining 
the effects on comorbid PDs (e.g., Bovin, Wolf, & 
Resick, 2017; Markowitz et al., 2015), particularly 
borderline personality disorder (BPD; e.g., Harned, 
Korslund, & Linehan, 2014). These studies showed 
that change in PTSD severity was associated with 
change in symptom severity of these disorders, in 
comorbid PD features and/or loss of PD diagnosis.
One of the evidence-based therapies that has been 
found effective in treating the psychological conse-
quences of exposure to adverse childhood events is eye 
movement desensitization and reprocessing (EMDR) 
therapy (De Jongh, Amann, Hofmann, Farrell, & Lee, 
2019; Van Veen et al. 2015; World Health Organization, 
2013). The effects of EMDR therapy on symptoms of 
PDs has been studied in a sample of patients who were 
also diagnosed with PTSD (Slotema, van den Berg, 
Driessen, Wilhelmus, & Franken, 2019). The results of 
this uncontrolled pilot study showed that the application 
of EMDR therapy was associated with a significant 
reduction of PTSD symptom. However, the effects of 
EMDR therapy on symptoms characteristic of patients’ 
PD were not examined. More generally, whether patients 
with a PD respond to evidence-based therapy focused on 
memories of adverse events not underlying PTSD is 
largely unknown.
The purpose of the present study was to evaluate 
the effectiveness of EMDR therapy on psychological 
symptoms and functioning in patients with a PD 
using a randomized-controlled trial design. We 
hypothesized that patients’ global level of psycho-
logical symptoms, psychological distress and per-
sonality dysfunctioning would decrease associated 
with the application of EMDR therapy (i.e. aimed 
at the resolution of memories of adverse, non- 
criterion A events), in comparison with a control 
group not receiving EMDR. In addition, it was 
hypothesized that these changes would be main-




Patients were recruited at three outpatient clinics of 
a specialized psychiatric institute in the Netherlands, 
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GGZ Delfland (locations Delft, Naaldwijk and 
Ypenburg). A sample of 97 patients with a PD diag-
nosed following the criteria of the Diagnostic and 
Statistical Manual of mental disorders (DSM-5) parti-
cipated in the study. Patients were eligible for participa-
tion if they met the following inclusion criteria: 1) a PD 
as primary diagnosis according to the DSM-5 criteria; 2) 
between 18 and 65 years old. Exclusion criteria were 1) 
a diagnosis of PTSD, 2) a high suicide risk as operatio-
nalized by a suicide attempt within the past 6 months, 
current suicidal intention or severe automutilation, 
and 3) an inability to read or write the Dutch language. 
Comorbidity of other mental disorders was not an 
exclusion criterion. Patients in addiction withdrawal 
were not included. The secondary diagnoses of the 
included patients varied: the most prevalent diagnoses 
were mood disorders, anxiety disorders, personality 
disorders and ADHD. Thirty-three percent of the 
patients had three or more secondary diagnoses, 37% 
had two secondary diagnoses and 30% had one second-
ary diagnosis. During the study, patients did not receive 
any other adjacent treatments, except continuation of 
pharmacological treatment. During the study no 
changes in drug treatment were made and the posology 
of drug treatment was stable before inclusion. 
Participants were compensated with travelling costs to 
the appointments. Inclusion and follow-up continued 
from November 2017 until July 2019.
2.2. Design and randomization
A randomized-controlled trial was carried out in 
which patients were allocated to either five sessions 
EMDR therapy (5 weekly sessions of 90 minutes, 
7.5 hours of EMDR therapy in total) or a waiting 
list control condition (a period of 5 weeks). After five 
weeks of EMDR or five weeks of waiting list, patients 
in both conditions received TAU for their PD. After 
3 months of TAU patients in both groups completed 
follow-up measurements. All procedures involving 
the trial complied with the ethical standards of 
the relevant national and institutional committees 
on human experimentation and with the Helsinki 
Declaration of 1975, as revised in 2008, and 
were approved by The Medical Ethics Committee 
South West Holland, registered as NL61845.098.17. 
Although for various reasons we were only able to 
complete the registration of the trial after the start of 
the study (https://www.trialregister.nl/trial/7470) the 
purpose, aims, hypotheses, study design, data collec-
tion, analytical strategy and planned statistical ana-
lyses have remained unchanged since the beginning 
of the study. Allocation was performed by a blocked 
stratified randomization with a block size of four and 
stratification by PD cluster. Actual randomization 
was performed by an independent secretary and 
researchers were blind to the allocation order. 
Included patients received a research number on 
order of entry.
2.3. Procedures
Eligible patients were informed about the study by 
their mental health professional. If a patient was inter-
ested the researcher contacted the patient to check the 
exclusion and inclusion criteria and to answer possible 
questions. Assessments were conducted after randomi-
zation at baseline, post-treatment and at three-month 
follow up.
The Structured Clinical Interview DSM-5 (SCID-5; 
First, Williams, Karg, & Spitzer, 2016) was adminis-
tered by independent and trained psychologists to 
classify a PD. PTSD was ruled out using the MINI 
International Neuropsychiatric Interview (Sheehan 
et al., 1997). Next, a written informed consent was 
obtained from all patients and patients were ran-
domly assigned to either the experimental group or 
the control group. Patients were asked permission to 
record the EMDR sessions, in order to address adher-
ence to the EMDR standard protocol (De Jongh & 
Ten Broeke, 2012). After the therapy or the waiting 
period, patients received treatment as usual for 
their PD.
The participants in the EMDR group filled in the 
questionnaires at the treatment location. Patients in 
the control group completed the questionnaires in 
a secured online system from their home location. 
The follow-up measurement was filled in at home, 
patients were prompted by telephone and email to 
complete the questionnaires. Adverse events such as 
severe suicidal ideation, crisis contacts or admission 
to a hospital were monitored by the therapists.
3. Measures
3.1. Outcome measures
Severity of psychological symptoms was measured 
with the Brief Symptom Inventory (BSI; de Beurs & 
Zitman, 2005) at baseline, post-treatment and at 
3 months follow up in the experimental group, or at 
baseline, after 5 weeks and at 3 month follow-up in 
the control group. The BSI includes three global 
indices of distress (Global Severity Index, Positive 
Symptom Distress, and Positive Symptom Total), 
which measure the overall psychological distress 
level, the intensity of symptoms, and the number of 
self-reported symptoms. In this study, the total scores 
were analysed. Higher total scores reflect higher level 
of symptoms.
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Level of psychological distress was measured with 
the Outcome Questionnaire-45 (OQ-45, Lambert & 
Finch, 1999). This questionnaire measures three 
domains of functioning: symptom distress, interper-
sonal relations and social role performance). The 
OQ-45 consists of 45 items and is a self-report scale 
with good psychometric properties (De Jong et al., 
2007). Higher total scores reflect a higher level of 
psychological distress. Total levels of psychological 
distress were measured at baseline, post-treatment 
and after 3 months in the experimental group, or at 
baseline, after 5 weeks and after 3 month follow-up in 
the control group.
During the trial, it was decided to also index global 
level of personality dysfunctioning. This means that 
an already randomized subsample filled out the 
General Assessment of Personality Disorder (GAPD; 
Berghuis, 2007; Livesley, 2006). The GAPD is a self- 
report questionnaire designed to evaluate general 
personality dysfunctioning. The measure evaluates 
two major components of disordered personality 
(i.e. self or identity problems and interpersonal dys-
function) with higher scores reflecting a higher level 
of dysfunctioning.
3.2. Treatment
EMDR therapy is a standardized, eight-phase, 
trauma-focused therapy consisting of dosed, sequen-
tially applied attention directed at the disturbing 
memory, while at the same time the attention of the 
patient is directed to another concurrent (dual- 
attention) task. Typically, this task involves patients 
following the therapist’s moving fingers with their 
eyes (for a description of EMDR therapy see: 
https://www.emdria.org/about-emdr-therapy/). In 
the present study the standard eight-phase EMDR 
protocol (De Jongh & Ten Broeke, 2012; Shapiro, 
2018) was applied. Patients were first informed 
about EMDR therapy, memories were identified, 
and the course of current symptoms was evaluated. 
Next, a case conceptualization was conducted based 
upon patient’s current symptoms, specifying mem-
ories of the aetiological and/or aggravating disturbing 
events using a timeline to structure the order of the 
memories to be targeted (i.e. ‘First method’; De 
Jongh, Ten Broeke, & Meijer, 2010). For example, if 
symptoms of fear of abandonment were most promi-
nent in someone’s PD, the memories of events that 
were assumed to play a key role in the acquisition and 
maintenance of this fear, and evoked distress, were 
identified, selected and processed in the order in 
which these events had taken place over time’. After 
having processed one memory (i.e. SUD = 0; 
VOC = 7), EMDR therapy continued by targeting 
the following memory on the timeline. In that way 
all memories that were considered to contribute to 
a patient’s current symptoms were targeted using the 
EMDR standard protocol.
Immediately after randomization, the baseline mea-
surement took place for both groups. Next, the EMDR 
group received five weekly sessions of EMDR, did the 
post-treatment assessment after these five weeks, fol-
lowed by 3 months of TAU and subsequently did the 
follow-up assessment. Duration of the EMDR sessions 
was 90 minutes. An average of five memories per 
person in total were targeted. The control group was 
five weeks on a waiting list (for the TAU), and did the 
assessment after these five weeks, followed by 3 
months of TAU, and subsequently did the follow-up 
assessment. Treatment as usual (TAU) was not stan-
dardized. Different treatments were indicated. Most 
patients in both groups received schema-focused ther-
apy (48.3%). Other patients received Competetive 
Memory Training COMET (Korrelboom, Marissen, 
& van Assendelft, 2011); 11.5%), emotion regulation 
therapy (11.5%), interpersonal sensitivity training 
(5.7%), mentalization-based therapy (2.3%), cognitive 
behavioural therapy (2.3%), young adults psychody-
namic group (4.6%), another kind of therapy (2.3%) 
or no therapy (11.5%). The various types of TAU did 
not significantly differ per group (p = .16). In case of 
crisis, patients could contact their therapist.
3.3. Treatment training and integrity
Twelve therapists in total were involved in this study. 
They were trained and experienced in administering 
EMDR therapy and completed an EMDR Europe 
accredited training organized by the Dutch EMDR 
Association. During the study all therapists partici-
pated in supervision sessions in a small group, led by 
registered VEN supervisor and EMDR trainer (AdJ). 
They received feedback on the recorded therapy ses-
sions and different questions were addressed. Also, 
adherence to the EMDR protocol was verified. When 
necessary, the first author had contact with the thera-
pists about progress of the sessions and answered 
questions about adherence to the protocol.
4. Statistical analysis
A priori power analyses based on the LMM procedure 
indicated that 86 participants (43 per group) were 
needed to have 95% power to detect an effect size 
(Cohen’s d) of .25 between the EMDR condition and 
control group with an alpha of .05 and a power of .95. 
A priori, additional patients were included to compen-
sate in case attrition would occur. Baseline differences 
were analysed using parametric and nonparametric 
tests, as appropriate. Between-group comparisons on 
primary and secondary outcomes were carried out per 
the intention-to-treat principle using linear-mixed 
models (LMM) including all randomized participants 
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regardless of missing data. A random intercept was 
included in the models. Within-group comparisons 
between baseline values and follow-up values were 
corrected for multiple testing using the Holm- 
Bonferroni method. Between-group differences at the 
two follow-up moments were also corrected for multi-
ple testing using the Holm-Bonferroni method. In the 
linear mixed model analysis, we have used the method 
of Sidak to correct for multiple comparisons. The 
covariance structure that gave the best model fit was 
chosen, based on Akaike’s Information Criterion 
(autoregressive). Model-selection was performed on 
each outcome measure. The main parameter of inter-
est was the group by time interaction, indicating 
a different outcome pattern over time between both 
groups. P-values of < .05 were considered statistically 
significant. All tests were two-tailed. Given that 
Cohen’s d was used to assess the magnitude of effect, 
an effect size of .2 or less was considered as a small 
effect, .5 as a medium effect, and .8 or greater as 
a large effect. Effect sizes were calculated by dividing 
the mean difference (within and between groups) by 
the pooled standard deviation. Data analysis was per-
formed with the SPSS version 25.
5. Results
5.1. Patient flow and sample characteristics
Figure 1 shows the flow chart of participants 
through the trial, the dropout and loss to follow- 
up. No significant differences were found between 
the two groups in any of the baseline characteristics 
(Table 1) or the baseline scores. No significant dif-
ferences in drug therapy between the two groups 
were found.
5.2. Effectiveness of treatment
In both groups prior to the follow-up measurement 
patients received an average of five sessions of the 
indicated treatment as usual for their personality 
disorder (PD). Figure 2 shows the results of the 
Linear Mixed Model (LMM) analysis of the primary 
Figure 1. Participant flow.
EMDR, eye movement desensitization and reprocessing therapy; SUD, subjective unit of disturbance 
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and secondary outcome: psychological symptoms 
and psychological distress over time and the statis-
tics for the within-groups as well as the between 
groups differences. Table 2 presents the means and 
standard deviations, LMM test statistics and effect 
sizes (d) at post-treatment and at 3 months of follow 
up for the two outcome measures. We also present 
the p-value for the group by time interaction, ana-
lysed by the linear mixed model analysis. Because of 
the small number of PDs within each type of PD, we 
did not conduct any additional analyses between the 
different PDs. Table 3 presents the relevant para-
meter estimates of the fixed effects of the LMM 
analysis.
Table 1. Demographic characteristics divided by allocated group (n = 97) and comparisons between groups.
Variable Control group EMDR group* Statistic
Mean age (years) 32.85 (range 18–63) 33.67 (range 18–64) F (1) = 0.11, p = .75

















X2 (2) = 0.02, p = .99






















X2 (6) = 6.30, p = .39
Figure 2. Differences between the groups on psychological symptoms and psychological distress over time measured with the 
BSI and OQ-45.
*M1 = baseline measurement; M2 = post-treatment measurement; M3 = 3-month follow-up measurement; BSI = Brief Symptom Inventory; OQ- 
45 = Outcome Questionnaire-45 
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5.3. Pre-to-post treatment changes per group
EMDR participants reported significant pre-to-post 
treatment reductions in psychological symptoms, as 
indexed by the Brief Symptom Inventory (BSI), with 
medium effect sizes (EMDR: d = .42, CI; .01, .82; control 
group: d = .07, CI; −.35, .49) after 7.5 hours of EMDR. 
Likewise, significant pre-to-post treatment improve-
ments in psychological distress as indexed by the 
Outcome Questionnaire (OQ) after EMDR therapy 
(EMDR: d = .69; CI; .27, 1.10; control group: d = .29), 
CI; −.13, .71) were found, with medium effect sizes. 
Global level of personality dysfunctioning was indexed 
using the General Assessment of Personality Disorder 
(GAPD) in a subsample (28 EMDR patients and 26 
control group patients). The results on this outcome 
measurement were in line with the other outcomes 
(EMDR: d = .41; CI; −.14, .95; control group: d = −.10, 
CI; −.64, .46).
5.4. Changes at 3-month follow-up
At 3-month follow-up, after both groups followed 3 
months of TAU, medium to large effect sizes were 
maintained regarding psychological symptoms (BSI; 
EMDR: d = .66, CI; .22, 1.08; control group: d = .41, 
CI; −.04, .84), psychological distress (OQ; EMDR: 
d = .86, CI; .42, 1.29; control group: d = .62, CI; .17, 
1.05), and personality dysfunctioning (GAPD; 
EMDR: d = .50, CI; −0.09, 1.08; control group: 
d = .23, CI; .23, 0.79).
5.5. Differences between EMDR therapy and 
control group
Over the three measurement points, significant differ-
ences between the groups in psychological symptoms 
and psychological distress were found in favour of the 
EMDR group (see Table 2). Regarding personality 
dysfunctioning, Cohen’s d effect sizes of EMDR versus 
the control group were −.68, 95% CI [−1.24, −.10] at 
post-treatment, and −.41, 95% CI [−1, .20] at follow 
up, with a significant difference between the groups in 
favour of the EMDR group (p = .007).
6. Discussion
The results of this study show that EMDR therapy 
yielded significant improvements with medium, 
intent-to-treat effect sizes for psychological symp-
toms, psychological distress, and personality func-
tioning. These findings are particularly important 
because the treatment given was brief, whereas the 
gains were maintained at follow-up, following 3 
months of treatment as usual (TAU).
As far as we are aware this is the first study 
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memories of adverse events of patients with a PD 
without PTSD and the influence on TAU. 
A number of previous studies focused on the treat-
ment of PTSD in patients with a PD as a comorbid 
disorder (e.g., Bovin et al., 2017; Harned 2013; 
Harned et al., 2014; Markowitz et al., 2015; Slotema 
et al., 2019) and found significant effects on symp-
toms of both PTSD and PD features. However, in 
these studies interventions pertained to traumatic (i.e. 
A criterion worthy) events underlying PTSD, while in 
the present study PTSD was excluded. In the present 
study target memories for EMDR therapy were 
selected based upon patients’ current symptoms 
while the therapists identified keystone memories 
involving aetiological and/or aggravating adverse 
(childhood) events. Although different than previous 
approached the current findings are in line with other 
research findings and arguments (e.g. Markowitz 
et al., 2015) stemming from the notion that proces-
sing disturbing memories would not only have 
a positive effect on people’s daily functioning, but 
also on symptom clusters (e.g. social withdrawal, 
avoidance, mistrust, low self-esteem) that are consid-
ered as specific for personality pathology.
The only other study that has applied EMDR therapy 
in the treatment of PD before was an uncontrolled open 
pilot study with patients who also suffered from PTSD 
(Slotema et al., 2019). Patients received treatment for 
their PD while in the same period EMDR therapy was 
applied in order to reduce typical trauma-related symp-
toms. This appeared beneficial in terms of a significant 
reduction of PTSD symptoms, but also of comorbid 
symptoms such as dissociation and insomnia. The med-
ian number of sessions of completers (the drop out was 
32%) was four sessions of 60–90 minutes, but was applied 
as an addition to treatment as usual for personality dis-
orders. In the present study the patients did not receive 
other forms of treatment before post-treatment measure-
ment, length of treatment was brief in that patients 
received only 7.5 hours of EMDR therapy in total, and 
improved significantly. Between post-treatment and fol-
low-up, patients received an average of five sessions TAU 
for PD within the 3 month before the follow up measure-
ment. Overall, this is much shorter than in previous 
studies, including Markowitz et al. (2015) study who 
applied a treatment aimed at treating chronic PTSD 
that lasted 14 weeks, Bovin et al. (2017) who used 
13 hours of therapist contact in total, and Harned et al. 
(2014) whose patients received one full year of dialectical 
behaviour therapy, existing of 1-h individual therapy, 
and two and a half hours group skills training per week 
later combined with the Dialectical Behaviour Therapy 
Prolonged Exposure Protocol.
The present study has several limitations that need 
to be noted. Firstly, one limitation is that the control 
group was a non-intervention waiting list group, 
which served as an untreated comparison for the 
experimental group. Clearly, in future studies, it 
would be more appropriate to add an active treatment 
control group. Our intention was to compare an active 
and established therapy with a waiting list control 
group as a comparator followed by treatment as 
usual, given that this was the first study ever conducted 
to examine the effect of EMDR therapy in patients 
with personality disorders without PTSD and this 
design made it possible to control for the effects of 
natural recovery, which is not possible with an active 
comparator alone. Secondly, due to the small number 
of each type of PD we were not able to determine 
differences between the PDs. Thirdly, we did not assess 
the loss of PD diagnoses post-treatment and only 
considered therapeutic gains during treatment for 
which we merely used proxy measures for the 
PDs. These do not accurately reflect the corresponding 
PD clusters, thus introducing some measurement bias. 
Therefore, future research should explore the long- 
term outcomes of these interventions. Fourthly, the 
follow-up measurement took place 3 months after 
treatment as usual (TAU) for the PDs started. This 
treatment included different interventions, such as 
those aimed at emotion regulation, schema-focused 
therapy or competitive memory training (COMET). 
Although this study was a good presentation of clinical 
practice and no significant differences in TAU or 
amount of sessions between the two groups were 
found, it may have caused an overestimation of the 
study treatment effects. A point of discussion pertains 
to the exclusion of individuals with PTSD. In the 
period the study was carried out, our mental health 
institution was in the transition of the DSM-IV-TR to 
Table 3. Parameter estimates of the fixed effects of the LMM analysis.
Fixed Effects BSI Fixed Effects OQ-45
Est/Beta SE 95% CI t p Est/Beta SE 95% CI t p
Intercept 1.50 0.09 1.32 – 1.68 16.73 <.001 88.37 2.65 83.11 – 93.63 33.36 <.001
Group 0.18 0.13 −0.08 – 0.44 1.37 .174 5.39 3.86 −2.27 – 13.05 1.40 .166
Post-treatment −0.28 0.06 −0.41 – -0.16 −4.45 <.001 −13.80 2.22 −18.20 – 9.41 −6.21 <.001
Follow up −0.42 0.09 −0.60 – -0.24 2.32 .053 17.87 3.26 11.42 – 24.32 5.48 <.001
Group * 
Post-treatment
0.24 0.09 0.06 – 0.42 2.60 .010 2.49 3.19 1.64 – 14.24 2.49 .014
Group * Follow up 0.15 0.13 −0.11 – 0.41 1.16 .248 5.15 4.67 −4.10 – 14.40 1.10 .272
Model Fit Model Fit
AIC 389.63 2197.77
*BSI: brief symptom inventory; OQ-45: outcome questionnaire 45. 
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the DSM-5. Therefore, patients were classified as hav-
ing PTSD during intake using a clinical interview for 
which we used the MINI Plus based upon DSM-IV- 
TR, rather than upon DSM-5, criteria. Although it 
could be argued that this is a potential limitation for 
interpreting the results, this probably has had little 
influence on the application of the exclusion criterion 
(i.e. absence of PTSD; see, for example Hoge, Riviere, 
Wilk, Herrell, & Weathers, 2014). Another limitation 
of the study is that randomization took place right 
before the baseline measurement, which could have 
influenced the baseline scores.
A few strengths of the study should also be men-
tioned. Firstly, the sample size of 97 patients and the fact 
that the study was carried out in three different out-
patient clinics with patients suffering from severe psy-
chopathology makes the study exemplar for clinical 
practice. Secondly, the treatment was well tolerated 
(only one participant, from the control group, needed 
to be hospitalized because of alcohol abuse, and the 
dropout rate was lower than in previous studies using 
trauma-focused psychotherapy, including those with 
a severe mental illness (about 30%; Kredlow et al., 
2017; Slotema et al., 2019). Yet, the dropout rate of 
patients with a Cluster B personality disorder was sig-
nificantly higher than those with other PDs. This is in 
accordance with earlier studies. Features such as inter-
personal sensitivity, emotional lability, anger and impul-
sivity are believed to play a contributing role (Wnuk 
et al., 2013). Finally, we were able to constantly monitor 
treatment adherence during monthly supervision ses-
sions for which every therapist in the study needed to 
show videos of their treatment sessions.
In conclusion, the results of this study show that 
a brief intensive treatment focused on memories of 
individuals’ adverse events can be beneficial for those 
diagnosed with a PD to reduce psychological symp-
toms and to improve their functioning, suggesting 
that individuals with PDs can benefit from EMDR 
without any additional stabilizing interventions and 
no significant exacerbation of their symptoms. There 
is clearly a need for further well-designed trials of 
therapies for PDs that incorporate more treatment 
sessions and long-term outcome monitoring.
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